6505-00-770-2061 ( NDC00054-4043-25 , NDC00364-0575-01 , NDC00038-0041-10 , NDC00140-0109-01 , NDC00310-0041-10 , NDC00603-2214-21 , NDC00310-0041-10 , NDC00228-2133-10 , NDC00781-1488-01 , ENDEP , NDC43567-0540-01 , NDC00182-1020-01 , ELAVIL )
NSN Information
NSN | FSC | NIIN | Item Name | INC |
---|---|---|---|---|
6505-00-770-2061 | 6505 | 007702061 | AMITRIPTYLINE HYDROCHLORIDE TABL | 3090 |
NSN Features
MRC | Parameter | Characteristics |
---|---|---|
SUCB | UNIT OF ISSUE CUBE | 0.010 CUBIC FEET |
AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 50.000 MILLIGRAMS AMITRIPTYLINE HYDROCHLORIDE ACTIVE INGREDIENT |
THPE | THERAPEUTIC EQUIVALENT | ENDEP BY ROCHE |
CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | AMITRIPTYLINE HYDROCHLORIDE TABLETS USP 50MG 100S BT |
SUWT | UNIT OF ISSUE WEIGHT | 0.15 POUNDS |
CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
PKQT | INTERMEDIATE PACKAGE QUANTITY | 12 |
EXME | EXTERIOR CONTAINER CUBIC MEASURE | 0.82 CUBIC FEET |
EXQT | EXTERIOR CONTAINER QUANTITY | 144 |
CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
CSGS | ADMINISTRATION | ORAL |
ECWT | EXTERIOR CONTAINER WEIGHT | 29.00 POUNDS |
Manufacturing Part Numbers (SKUs)
Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
---|---|---|---|---|---|---|---|
NDC00054-4043-25 | 34471 | A | 9 | 5 | 4 | ZZ | |
NDC00364-0575-01 | 0PTT8 | A | 2 | 5 | 4 | ZZ | |
NDC00038-0041-10 | 13992 | A | 9 | 5 | 4 | ZZ | |
NDC00140-0109-01 | 04493 | A | 9 | 5 | 4 | KX | |
NDC00310-0041-10 | 13992 | A | 2 | 3 | 4 | ZZ | |
NDC00603-2214-21 | 0ET99 | A | 2 | 3 | 4 | ZZ | |
NDC00310-0041-10 | 0A273 | A | 2 | 3 | 4 | ZZ | |
NDC00228-2133-10 | 56287 | A | 9 | 5 | 4 | ZZ | |
NDC00781-1488-01 | 0THL4 | A | 2 | 3 | 4 | ZZ | |
ENDEP | 04493 | A | 1 | 5 | 4 | KX | |
NDC43567-0540-01 | 6V917 | F | 2 | 5 | 4 | ZZ | |
NDC00182-1020-01 | 2U436 | A | 9 | 5 | 4 | ZZ | |
ELAVIL | 13992 | A | 1 | 5 | 4 | ZZ |
Manufacturers
Part SKU | Cage | Manufacturer | Type | Status |
---|---|---|---|---|
NDC00054-4043-25 | 34471 | BOEHRINGER INGELHEIM ROXANE INC. | A | A |
NDC00364-0575-01 | 0PTT8 | SCHEIN PHARMACEUTICAL INC | A | A |
NDC00038-0041-10 | 13992 | ZENECA INC | A | A |
NDC00140-0109-01 | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
NDC00310-0041-10 | 13992 | ZENECA INC | A | A |
NDC00603-2214-21 | 0ET99 | GENERICS BIDCO I LLC | F | A |
NDC00310-0041-10 | 0A273 | ASTRAZENECA LP | A | A |
NDC00228-2133-10 | 56287 | ACTAVIS INC | A | A |
NDC00781-1488-01 | 0THL4 | SANDOZ INC. | F | A |
ENDEP | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
NDC43567-0540-01 | 6V917 | MD PHARMACEUTICAL CO | F | F |
NDC00182-1020-01 | 2U436 | GOLDLINE LABORATORIES | A | A |
ELAVIL | 13992 | ZENECA INC | A | A |
FLIS Identification
PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
---|---|---|---|---|---|---|---|---|---|---|
A | X | A | 03/15/1 | P | 3004909135 | 3090 |
FLIS Management
MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
---|---|---|---|---|---|
DS | I | K | U/I CONTAINS 100 TT | ||
DA | C2201X- | A | K | U/I CONTAINS 100 TT | |
VA | V | K | U/I CONTAINS 100 TT | ||
DN | 9B----- | N | K | U/I CONTAINS 100 TT | |
DF | ------- | F | K | U/I CONTAINS 100 TT |
Demilitarization Codes & Management
DML | PMI | HMIC | ADP | CC | ESDC |
---|---|---|---|---|---|
A | A | P | X |
Miscellaneous Management
MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
---|---|---|---|---|---|---|---|---|---|
DN | SMS | L | 1 | BT | Q | U | 9B----- | N | |
DF | SMS | L | 1 | BT | Q | U | ------- | F | |
VA | I | 0 | BT | Q | U | V | |||
DS | SMS | L | 1 | BT | Q | U | D | ||
DA | SMS | L | 1 | BT | Q | U | C2201X- | A |
Management Control Army
MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
---|---|---|---|---|
C | 2 | 2 | 01 | X |
Freight
NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
---|---|---|---|---|---|---|---|---|---|---|---|---|
058770 | Z | 33400 | W | 532 | H | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |